TREAT PTSD Act
Sponsored By: Representative Perry, Scott [R-PA-10]
In Committee
Summary
This bill would expand access to stellate ganglion block (SGB) as a treatment option for post‑traumatic stress disorder (PTSD). It directs the Departments of Veterans Affairs and Defense to offer SGB to eligible veterans and service members who choose it after being informed about risks and benefits.
Show full summary
- Veterans: Veterans enrolled in VA care with a PTSD diagnosis could elect to receive SGB after counseling from a qualified health care provider. Care may be provided at VA medical facilities or through specified outside providers.
- Active‑duty service members and reservists: Members enrolled in the TRICARE program who have PTSD could elect SGB after informed consent. The Department of Defense could deliver SGB at military medical facilities or via TRICARE participating providers.
- Clinical guidance and timing: The VA and DoD would have to update the VA/DoD Joint Clinical Practice Guideline for PTSD within 180 days to add SGB as an option and to list clinical indicators and contraindicators. The changes to coverage would take effect 180 days after enactment and the Secretaries must notify relevant congressional committees after the guideline is updated.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
PTSD nerve block for vets and troops
If enacted, eligible veterans and service members could get a nerve block treatment (stellate ganglion block) for PTSD. Veterans would need to be enrolled in VA care. Troops, including reservists who have performed active service, would need to be enrolled in TRICARE. You must have a PTSD diagnosis and choose the treatment after a qualified provider explains risks and benefits. Care could be at VA/DoD facilities or through approved outside providers. This would start 180 days after enactment.
PTSD guideline adds nerve block option
If enacted, the VA and DoD would update their joint PTSD care guideline within 180 days. The update would list stellate ganglion block as a treatment option and explain when it should or should not be used. After the update, the agencies would notify the defense and veterans’ affairs committees in Congress.
Sponsors & CoSponsors
Sponsor
Perry, Scott [R-PA-10]
PA • R
Cosponsors
Rep. Ogles, Andrew [R-TN-5]
TN • R
Sponsored 3/6/2025
Rep. Gosar, Paul A. [R-AZ-9]
AZ • R
Sponsored 3/6/2025
Nehls
TX • R
Sponsored 3/6/2025
Crenshaw
TX • R
Sponsored 3/6/2025
Rep. McCormick, Richard [R-GA-7]
GA • R
Sponsored 3/6/2025
Rep. Fitzpatrick, Brian K. [R-PA-1]
PA • R
Sponsored 3/6/2025
Rep. Valadao, David G. [R-CA-22]
CA • R
Sponsored 3/6/2025
Rep. Houlahan, Chrissy [D-PA-6]
PA • D
Sponsored 4/21/2025
Rep. Dean, Madeleine [D-PA-4]
PA • D
Sponsored 5/5/2025
Rep. Murphy, Gregory F. [R-NC-3]
NC • R
Sponsored 6/2/2025
Bilirakis
FL • R
Sponsored 6/4/2025
Van Drew
NJ • R
Sponsored 6/11/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov